Table 1.
Details of patient-derived fibroblasts
| CATALOG NO. | GENDER | AGE | AFFECTED | DESCRIPTION |
|---|---|---|---|---|
| AG07613 | MALE | 66 | YES | FAMILIAL, TYPE 3 |
| AG07768 | MALE | 45 | YES | FAMILIAL, TYPE 3 |
| AG08170 | MALE | 56 | YES | FAMILIAL, TYPE 3 |
| AG08527 | MALE | 61 | YES | SPORADIC |
| AG09955 | FEMALE | 47 | YES | APOLIPOPROTEIN E; APOE |
| NG10039 | FEMALE | 29 | YES | APOLIPOPROTEIN E; APOE |
| NG10788 | NA | 87 | YES | APOLIPOPROTEIN E; APOE |
| NG11757 | FEMALE | 81 | YES | APOLIPOPROTEIN E; APOE |
| NG00364 | MALE | 53 | YES | SPORADIC |
| NG04159 | FEMALE | 52 | YES | FAMILIAL, TYPE 3 |
| NG05809 | FEMALE | 63 | YES | SPORADIC |
| NG05810 | FEMALE | 79 | YES | APOLIPOPROTEIN E; APOE |
| NG06205 | MALE | 67 | YES | SPORADIC |
| NG06265 | MALE | 61 | YES | SPORADIC |
| NG06840 | MALE | 56 | YES | PRESENILIN 1; PSEN1 |
| AG04402 | MALE | 47 | YES | APOLIPOPROTEIN E; APOE |
| AG11414 | MALE | 39 | YES | APOLIPOPROTEIN E; APOE |
| AG05810 | FEMALE | 79 | YES | APOLIPOPROTEIN E; APOE |
| AG21158 | FEMALE | 69 | YES | APOLIPOPROTEIN E; APOE |
| AG11369 | FEMALE | 50 | YES | SPORADIC |
| AG07123 | MALE | 62 | NO | |
| AG04146 | MALE | 57 | NO | |
| AG02258 | FEMALE | 46 | NO | |
| AG02261 | MALE | 61 | NO |